Anonymous
Guest
Anonymous
Guest
Most of New England is closed down...and I mean zero access. Only RI and CT are decent. Most companies have very few reps left. When cuts come, these area's are cut to the bone. Thankfully, the managers are afraid to tell their managers the truth.
Pfizer has metrics they use now to determine what states and areas qualify as "share of voice" areas meaning reps can still impact the business to an extent that justifies keeping reps there.....needless to say Mass isn't one of these places. This is the entire point of LHE. Pfizer's new business model post Lipitor will not include PHRs and TSRs in places like Mass.